Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
5.33M
-
Shares change
-
+431K
-
Total reported value, excl. options
-
$7.9M
-
Value change
-
+$613K
-
Put/Call ratio
-
0.9
-
Number of buys
-
10
-
Number of sells
-
-13
-
Price
-
$1.48
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2021
42 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.33M shares
.
Largest 10 shareholders include Davy Global Fund Management Ltd (1.41M shares), BlackRock Inc. (842K shares), VANGUARD GROUP INC (654K shares), RENAISSANCE TECHNOLOGIES LLC (437K shares), Mirae Asset Global Investments Co., Ltd. (405K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (295K shares), GEODE CAPITAL MANAGEMENT, LLC (292K shares), STATE STREET CORP (170K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (139K shares), and BANK OF AMERICA CORP /DE/ (97K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.